Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Time to exit during the double blind phase (2 partial onset seizures with or without a secondarily generalized component, a secondarily generalized tonic clonic seizure when none existed prior to this phase, or 1 episode of status epilepticus).
Laboratory, vital signs, electrocardiogram data and adverse events reported during the trial.
3 Years and older (Child, Adult, Senior)
October 3, 2005
November 15, 2010
† Study has passed its completion date and status has not been verified in more than two years.